MEDX Health Corp.

MEDX Health Corp.

November 06, 2007 11:39 ET

MedX Health Corp. Obtains Receipt for Preliminary Prospectus

MISSISSAUGA, ONTARIO--(Marketwire - Nov. 6, 2007) -


MedX Health Corp. ("MedX") announces that it is proceeding with a public offering of a minimum of $4,000,000 and a maximum of $7,000,000 of units of MedX in the provinces of Ontario, British Columbia, Alberta and Manitoba and has obtained a decision document for its preliminary prospectus dated November 2, 2007. Each unit will be comprised of one common share and one warrant. Each warrant will entitle its holder to purchase one (1) additional common share at any time during the 24-month period following closing. The offering price for the units and the exercise price for the warrants will be determined prior to the filing of the final prospectus.

Research Capital Corporation is acting as agent for MedX's public offering.

The net proceeds of the prospectus offering will be used for expansion of distribution network, marketing program, product development for new dental, rehabilitation and wound care products, research and development for wound care study and for working capital purposes.

MedX has filed an application with the TSX Venture Exchange (the "Exchange") to list its common shares for trading. The listing on the Exchange will be subject to MedX fulfilling all the Exchange's listing requirements.

MedX's preliminary prospectus is available on the SEDAR website at

About MedX - MedX develops, manufactures and distributes phototherapy medical devices. MedX products are used by practitioners in clinics, academic facilities, hospitals as well as professional athletes and sports teams. MedX brand products are U.S. FDA and Health Canada cleared and are produced in an ISO 9001 and 13485 certified manufacturing and testing facility.

This press release is not an offer to sell or a solicitation of an offer to buy the units, nor shall there be any sales of the units in any jurisdiction in which such offer, solicitation, or sale would be unlawful. The securities offered pursuant to the public offering have not been and will not be registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or any applicable exemption from the registration requirement of such Act.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this press release.

Contact Information

  • MedX Health Corp.
    Phil Passy
    President and Chief Executive Officer
    (905) 826-0766